Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 02/02/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Mark Albertini MD | Apeiron Biologics, Vienna, Austria Array BioPharma Inc, Boulder, CO Bristol-Myers Squibb Company Merck & Co., Inc. Nektar Therapeutics |
None | None | None | 01/12/2023 |
| Christopher Barker MD | Alpha Tau Medical Amgen Inc. Elekta EMD Serono Merck & Co., Inc. Physical Sciences Incorporated (through subcontracted funds from NIH) Regeneron Pharmactcls |
Castle Biosciences Regeneron Pharmaceuticals, Inc. |
None | None | 11/03/2022 |
| Joel Baumgartner MD | None | None | None | None | 12/19/2022 |
| Shailender Bhatia MD | EMD Serono | None | None | Moderna | 06/24/2022 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Genevieve Boland PhD,MD | InterVenn Biosciences Olink Proteomics Palleon Pharmaceuticals Takeda Pharmaceuticals North America, Inc. Teiko |
Ankyra Therapeutics Instil Bio InterVenn Biosciences Iovance pharmaceuticals Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation |
Novartis Pharmaceuticals Corporation | Ankyra | 10/21/2022 |
| Bartosz Chmielowski MD,PhD | Adagene Advenchen Laboratories Ascentage Atreca Bristol-Myers Squibb Company Compugen Delcath IDEAYA Biosciences Immunocore Infinity Pharmaceuticals, Inc InstilBio Iovance Karyopharm Therapeutics Kezar Life Sciences Kinnate Macrogenics Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation PACT Pharma RAPT Therapeutics Replimune Trisalus Xencor Xilio |
Delcath Expert Witness InstilBio Nektar Therapeutics Novartis Pharmaceuticals Corporation |
None | None | 01/17/2023 |
| Dominick DiMaio MD | None | None | None | None | 11/23/2022 |
| Roxana Dronca MD | Alkermes Bristol-Myers Squibb Company Emerson Collective Phosplatin Therapeutics Regeneron Pharmactcls Sorento Therapeutics |
Bristol-Myers Squibb Company Eisai Inc. Elsevier, Inc. EMD Serono Genzyme Corporation Immunovaccine Technologies Natera |
Bristol-Myers Squibb Company Eisai Inc. Elsevier, Inc. EMD Serono Genzyme Corporation Immunovaccine technologies Natera |
None | 06/06/2022 |
| Ryan Fields MD | None | None | None | None | 01/14/2023 |
| Martin Fleming MD,FACS | Castle Biosciences | Castle Biosciences | None | None | 03/15/2022 |
| Anjela Galan MD | None | None | None | None | 11/30/2022 |
| Brian Gastman MD | Alkermes InstilBio Merck NIT |
BMS InstilBio Iovance Merck |
Castle Biosciences Quest Imaging |
Cutaneous Malignancies: A Surgical Perspective 1st Edition | 09/22/2022 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 09/27/2022 |
| Samantha Guild JD | None | Melanoma Research Program (CDMRP) State of Texas |
None | None | 01/16/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 12/12/2022 |
| Ashley Holder MD | None | None | None | None | 12/13/2022 |
| John Hyngstrom MD | Amgen Inc. Bristol-Myers Squibb Company Checkmate Iovance pharmaceuticals Lokon Merck & Co., Inc. Morphogenesis Naterra National Cancer Institute Oncosec Philogen |
None | None | None | 11/21/2022 |
| Douglas Johnson MD,MSCI | None | None | Bristol-Myers Squibb Company Catalyst Biopharma Iovance Mallinckrodt Merck & Co., Inc. Mosaic ImmunoEngineering Novartis Pharmaceuticals Corporation Pfizer Inc. Teiko |
Patent for MHC-II as a biomarker for immunotherapy response|Patient for abatacept or belatacept as treatment for refractory irAEs | 08/24/2022 |
| Madeline Joyce OCN,RN,BSN | None | None | None | None | 12/16/2022 |
| Giorgos Karakousis MD | Merck & Co., Inc. | Merck & Co., Inc. | None | None | 12/28/2022 |
| Ann Karosas BCOP,RPh | None | None | None | None | 01/04/2023 |
| Kari Kendra PhD,MD | Amgen Inc. checkmate pharmaceuticals Istari oncology medspace Merck & Co., Inc. National Institute on Aging Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | None | 12/24/2022 |
| Maija Kiuru PhD,MD | CalDerm NanoString Technologies, Inc. National Institute of Arthritis and Musculoskeletal and Skin Diseases |
None | None | None | 11/22/2022 |
| Rashmi Kumar PhD | None | None | None | None | 09/03/2022 |
| Julie Lange MD,ScM | None | None | None | None | 09/05/2022 |
| Ryan Lanning MD,PhD | None | None | None | None | 01/31/2023 |
| Theodore Logan MD,FACP | Abbott Laboratories Abraxis Bioscience, Inc. Acceleron Pharma, Inc. Amgen Inc. Argos Therapeutics AstraZeneca Pharmaceuticals LP AVEO Pharmaceuticals, Inc. Biovex Bristol-Myers Squibb Company Cerulean Pharma Dynavax Technologies Eisai Inc. Eli Lilly and Company EMD Serono GlaxoSmithKline Immatics Iovance pharmaceuticals MacroGenics MedImmune Inc. Merck & Co., Inc. Millennium Pharmaceuticals, Inc. NiKang Therapeutics Novartis Pharmaceuticals Corporation Peloton Therapeutics, Inc. Pfizer Inc. Prometheus Roche Laboratories, Inc. Synta Pharmaceuticals Corp. Threshold Pharmaceuticals TRACON Pharmaceuticals, Inc. |
None | None | None | 08/21/2022 |
| Senem Lubin PhD,MBA | None | None | None | None | 02/02/2023 |
| Miguel Materin MD | None | Castle Biosciences | None | None | 09/26/2022 |
| Lisa McKale | None | None | None | None | 01/30/2023 |
| Nicole McMillian MS | None | None | None | None | 10/10/2022 |
| Anthony Olszanski MD,RPh | Alkermes Astellas Pharma US, Inc. Bristol-Myers Squibb Company Checkmate Eutilex F-Star GlaxoSmithKline Glyconex InstilBio Intensity Istari Kadmon Kartos Kezar Kinnate OncoSec Pfizer Inc. Regeneron Pharmactcls Sumitomo Dainippon Takeda Pharmaceuticals North America, Inc. |
Bristol-Myers Squibb Company Eisai Inc. InstilBio Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
None | None | 02/02/2023 |
| Patrick Ott MD,PhD | Bristol-Myers Squibb Company Genentech, Inc. Merck & Co., Inc. Oncorus Xencor |
Bristol-Myers Squibb Company Evaxion Merck & Co., Inc. Pfizer Inc. Phio |
None | None | 05/24/2022 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 12/20/2022 |
| Merrick Ross MD | Amgen Inc. | Amgen Inc. Merck & Co., Inc. |
Amgen Inc. | None | 10/11/2022 |
| April Salama MD | Bristol-Myers Squibb Company Ideaya Immunocore Merck & Co., Inc. Nektar Therapeutics Olatec Regeneron Pharmactcls Replimune Seattle Genetics, Inc. |
Novartis Pharmaceuticals Corporation Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | 10/05/2022 |
| Rohit Sharma MD | None | None | None | None | 12/15/2022 |
| Arun Singh MD | None | AURA ISOAID LLC |
Immunocore | AURA | 08/31/2022 |
| Joseph Skitzki MD | None | None | None | None | 06/08/2022 |
| Emily Smith MD,FAAD | None | None | Gather-Ed | None | 11/18/2022 |
| Jeffrey Sosman MD | None | Array Jazz Pharmaceuticals Inc. Nektar Therapeutics Pfizer Inc. |
None | None | 10/06/2022 |
| Andrew Stacey MD,MS | None | None | None | None | 09/22/2022 |
| Susan Swetter MD | None | None | None | None | 01/17/2023 |
| Katy Tsai MD | Bristol-Myers Squibb Company Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Oncosec Pfizer Inc. Replimune |
Bristol-Myers Squibb Company | None | None | 06/07/2022 |
| Evan Wuthrick MD | None | None | Alpha Tau Castle Biosciences Viewray |
None | 06/06/2022 |
| Yan Xing PhD,MD | None | None | None | None | 10/18/2022 |